Vignesh Packiam, MD, discusses strategies to manage intravesical therapy toxicity in NMIBC, improve treatment tolerability, and preserve bladder function.
|Podcasts|July 30, 2021
Researchers evaluate data on priapism malpractice litigation
Author(s)Urology Times staff
“I think it's the responsibility of the physician to really take on educating and counseling and setting clear expectations and that way, when complications do arise, patients are better equipped, and they have a more favorable outcome,” says Ariana Matz, MD.
Advertisement
In this podcast, Ariana Matz, MD, discusses the Urology study, “Review of priapism litigation in the United States,” for which she served as a study author.
Advertisement
Related to this article
Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.
Advertisement
Advertisement
Trending on Urology Times
1
Adding darolutamide to ADT and radiation improves MFS in very high-risk localized prostate cancer
2
PROTEUS Substudy: Perioperative apalutamide plus ADT improves EFS vs surgery alone
3
Talazoparib/enzalutamide approved for HRR-mutated mAPMN/S prostate cancer
4
Daniel Heng, MD, highlights final LITESPARK-011 results in advanced ccRCC
5